TNFRSF1B and neoplasm: The in vivo imaging of tumours from mice with intraperitoneal injection demonstrated 100% metastatic tumour growth in control mice but 20% (1/5) in mice after being treated with anti‐TNFRSF1B antibodies (Figure 6I,J and Figure S5C,D).